TotalMarketCap

Collegium Pharmaceutical

COLLNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$816.495 M

$25.08 +5.96%

Close of 6 Nov 2026

As of 6 Nov 2026, Collegium Pharmaceutical (COLL) has a market capitalization of $816.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$780.6M

#1656 by revenue

Earnings

$63.0M

#1474 by earnings

Shares outstanding

31,075,424

Latest filing cover page

P/E ratio

13.0

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #157Corvus PharmaceuticalsCRVS$821.0M
  2. #158Aktis OncologyAKTS$820.9M
  3. #159Collegium PharmaceuticalCOLL$816.5M
  4. #160CryoportCYRX$813.4M
  5. #161AlumisALMS$756.5M

What if Collegium Pharmaceutical were worth as much as…

Open the what-if tool →

Gold $28.2T

$867,342.72

Per share 34,583× higher

Bitcoin $1.53T

$46,930.40

Per share 1,871× higher

Apple $5.02T

$154,068.14

Per share 6,143× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Collegium Pharmaceutical are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.